Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2015 1
2016 1
2017 1
2018 3
2019 1
2020 6
2021 6
2022 6
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura.
Izquierdo CP, Mingot-Castellano ME, Fuentes AEK, García-Arroba Peinado J, Cid J, Jimenez MM, Valcarcel D, Gómez-Seguí I, de la Rubia J, Martin P, Goterris R, Hernández L, Tallón I, Varea S, Fernández M, García-Muñoz N, Vara M, Zarzoso MF, García-Candel F, Paciello ML, García-García I, Zalba S, Campuzano V, Gala JM, Estévez JV, Jiménez GM, López Lorenzo JL, Arias EG, Freiría C, Solé M, Ávila Idrovo LF, Hernández Castellet JC, Cruz N, Lavilla E, Pérez-Montaña A, Atucha JA, Moreno Beltrán ME, Moreno Macías JR, Salinas R, Del Rio-Garma J. Izquierdo CP, et al. Blood Adv. 2022 Dec 27;6(24):6219-6227. doi: 10.1182/bloodadvances.2022008028. Blood Adv. 2022. PMID: 35930694 Free PMC article.
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.
Lahera A, Vela-Martín L, López-Nieva P, Salgado RN, Rodríguez-Perales S, Torres-Ruiz R, López-Lorenzo JL, Cornago J, Llamas P, Fernández-Navarro P, Sánchez-Domínguez R, Segovia JC, Sastre I, Cobos-Fernández MÁ, Menéndez P, Santos J, Fernández-Piqueras J, Villa-Morales M. Lahera A, et al. Among authors: lopez lorenzo jl. Br J Haematol. 2023 Aug;202(3):693-698. doi: 10.1111/bjh.18901. Epub 2023 Jun 2. Br J Haematol. 2023. PMID: 37264982 No abstract available.
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.
Bernal T, Moreno AF, de LaIglesia A, Benavente C, García-Noblejas A, Belmonte DG, Riaza R, Salamero O, Foncillas MA, Roldán A, Concepción VN, González LL, Bergua Burgués JM, Lorente de Uña S, Rodríguez-Macías G, de la Fuente Burguera A, García Pérez MJ, López-Lorenzo JL, Martínez P, Aláez C, Callejas M, Martínez-Chamorro C, Roca JR, Barciela LA, Mena Durán AV, Gómez Correcha K, Lavilla Rubira E, Amigo ML, Vall-Llovera F, Garrido A, García-Fortes M, de Miguel Llorente D, Leonardo AA, Cervero C, Jordá RC, Pérez-Encinas MM, Zarzuela MP, Figuera A, Rad G, Martínez-Cuadrón D, Montesinos P. Bernal T, et al. Cancer Med. 2023 Jul;12(14):14892-14901. doi: 10.1002/cam4.6120. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212507 Free PMC article.
Localized skin-limited blastic plasmacytoid dendritic cell neoplasm.
Suárez EU, Cornago J, Piris MÁ, Rodriguez Pinilla SM, López-Lorenzo JL, Soto C. Suárez EU, et al. Among authors: lopez lorenzo jl. EJHaem. 2022 Mar 1;3(2):560-562. doi: 10.1002/jha2.383. eCollection 2022 May. EJHaem. 2022. PMID: 35846036 Free PMC article. No abstract available.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M, Martínez-Sánchez P, Rodríguez-Medina C, Serrano J, Herrera P, Simón JAP, Sayas MJ, Bergua J, Lavilla-Rubira E, Amigo ML, Benavente C, Lorenzo JLL, Pérez-Encinas MM, Vidriales MB, Colorado M, De Rueda B, García-Boyero R, Marini S, García-Suárez J, López-Pavía M, Gómez-Roncero MI, Noriega V, López A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Solana-Altabella A, Boluda B, Montesinos P. Martínez-Cuadrón D, et al. Among authors: lorenzo jll. Haematologica. 2024 Jan 1;109(1):115-128. doi: 10.3324/haematol.2022.282506. Haematologica. 2024. PMID: 37199127 Free PMC article.
Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy.
López-Nevado M, Ortiz-Martín J, Serrano C, Pérez-Saez MA, López-Lorenzo JL, Gil-Etayo FJ, Rodríguez-Frías E, Cabrera-Marante O, Morales-Pérez P, Rodríguez-Pinilla MS, Manso R, Salgado-Sánchez RN, Cerdá-Montagud A, Quesada-Espinosa JF, Gómez-Rodríguez MJ, Paz-Artal E, Muñoz-Calleja C, Arranz-Sáez R, Allende LM. López-Nevado M, et al. Among authors: lopez lorenzo jl. J Clin Immunol. 2023 Jan;43(1):165-180. doi: 10.1007/s10875-022-01361-y. Epub 2022 Sep 6. J Clin Immunol. 2023. PMID: 36066697
ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
Pardo Gambarte L, Franganillo Suárez A, Cornago Navascués J, Soto de Ozaeta C, Blas López C, Atance Pasarisas M, Salgado Sánchez RN, Serrano Del Castillo C, Mata Serna R, Velasco Rodríguez D, López-Lorenzo JL, Llamas-Sillero P, Solán Blanco L. Pardo Gambarte L, et al. Medicina (Kaunas). 2022 Apr 6;58(4):520. doi: 10.3390/medicina58040520. Medicina (Kaunas). 2022. PMID: 35454359 Free PMC article.
Three monocytic neoplasms in a single patient.
Pérez-Sáenz MA, Rodriguez-Pinilla SM, Salgado RN, Carvajal N, Serrano C, Soto C, Serrano J, Atance M, López-Lorenzo JL, Requena L, Rojo F, Piris MA, Llamas P, Alonso-Dominguez JM. Pérez-Sáenz MA, et al. Leuk Lymphoma. 2020 Oct;61(10):2523-2526. doi: 10.1080/10428194.2020.1761966. Epub 2020 May 25. Leuk Lymphoma. 2020. PMID: 32449424 No abstract available.
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Bailén R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Vallés A, Esquirol A, Fonseca M, Solán L, Sánchez-Vadillo I, Bautista G, Bento L, López-Godino O, Pérez-Martínez A, Torrent A, Zanabili J, Calbacho M, Moreno MÁ, Pascual-Cascón MJ, Guerra-Domínguez L, Chinea A, García-Cadenas I, López-Corral L, Boix-Giner F, López Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernández-Caldas P, Anguita J, Kwon M. Bailén R, et al. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. Front Immunol. 2023. PMID: 37304258 Free PMC article.
Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
Schwartz JD, Barcellini W, Grace RF, Bianchi P, Zanella A, López Lorenzo JL, Sevilla J, Shah AJ, Glader B, Nicoletti E, Navarro Ordoñez S, Segovia JC. Schwartz JD, et al. Am J Hematol. 2022 Mar 1;97(3):E120-E125. doi: 10.1002/ajh.26458. Epub 2022 Jan 24. Am J Hematol. 2022. PMID: 34989415 Free PMC article. Review. No abstract available.
39 results